The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.
Source: NYT Health - Category: Consumer Health News Authors: Katie Thomas and Noah Weiland Tags: your-feed-science Antibodies Blood Donation Coronavirus (2019-nCoV) Clinical Trials Government Contracts and Procurement United States Politics and Government American Red Cross Food and Drug Administration Health and Human Services Depa Source Type: news
More News: Clinical Trials | Contracts | Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Government | Health | Learning | Politics | Science | Universities & Medical Training | USA Health